
    
      Phase 1- In the original study, 3 doses of Iloprost were given. This was revised after 5
      subjects were enrolled in order to study the effects of continuous delivery over a longer
      period of time.

      Phase 2 - All remaining subjects received Iloprost as a continuous treatment.

      The study was designed for an enrollment of 200 subjects and was ended early.
    
  